Adenovirus E1a as a tumor-suppressor gene.

Abstract:

:The E1a gene of group C adenoviruses is one of the most studied transforming genes of DNA tumor viruses. These transforming genes have been conventionally considered as dominant oncogenes since they transform cells in vitro and many of the resulting transformed cell lines induce tumors in experimental animals. It now appears that, in addition to its well-known transforming activities, E1a possesses activities which suppress transformation, tumorigenesis and malignant progression (metastasis) of tumor cells. Thus, E1a appears to meet the definition of both a dominant oncogene and a tumor-suppressor gene.

journal_name

Oncogene

journal_title

Oncogene

authors

Chinnadurai G

subject

Has Abstract

pub_date

1992-07-01 00:00:00

pages

1255-8

issue

7

eissn

0950-9232

issn

1476-5594

journal_volume

7

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.

    abstract::We have cloned and sequenced the nov gene (novH) which is the homolog of the chicken nov proto-oncogene overexpressed in avian nephroblastomas. The novH gene is highly conserved and encodes a putative IGF-binding protein similar to that of chicken. We report that relative to autologous normal kidney expression of novH...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Martinerie C,Huff V,Joubert I,Badzioch M,Saunders G,Strong L,Perbal B

    更新日期:1994-09-01 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway.

    abstract::Upregulation and activation of epidermal growth factor receptor and/or urokinase-type plasminogen activator receptor in a variety of cancers have been shown to be associated with poor prognosis. High-molecular-weight kininogen can be hydrolysed by plasma kallikrein to bradykinin and cleaved high-molecular-weight kinin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.132

    authors: Liu Y,Pixley R,Fusaro M,Godoy G,Kim E,Bromberg ME,Colman RW

    更新日期:2009-07-30 00:00:00

  • Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the CPP32-like protease activation and inducing the Bcl-2 expression.

    abstract::Mouse malignant T-lymphoma CS-21 cells grow in vitro in the presence of CA-12 lymph node stromal cells, but they undergo apoptotic cell death when separated from CA-12 stromal cells. In the course of examining the nursing effects of CA-12 stromal cells, we found that these cells provided some soluble factors that supp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lee SH,Fujita N,Mashima T,Tsuruo T

    更新日期:1996-11-21 00:00:00

  • Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.

    abstract::We have shown earlier that overexpression of Calreticulin (CRT) contributed to a poor prognosis for patients with esophageal squamous cell carcinoma (ESCC). Here, we have shown an important role of CRT in tumorigenesis through enhancing cell motility and anoikis resistance. SiRNA-mediated knockdown of CRT caused impai...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.237

    authors: Du XL,Yang H,Liu SG,Luo ML,Hao JJ,Zhang Y,Lin DC,Xu X,Cai Y,Zhan QM,Wang MR

    更新日期:2009-10-22 00:00:00

  • Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.

    abstract::Centrosome hyperamplification and the consequential mitotic defects contribute to chromosome instability in cancers. Loss or mutational inactivation of p53 has been shown to induce chromosome instability through centrosome hyperamplification. It has recently been found that Cdk2-cyclin E is involved in the initiation ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203460

    authors: Mussman JG,Horn HF,Carroll PE,Okuda M,Tarapore P,Donehower LA,Fukasawa K

    更新日期:2000-03-23 00:00:00

  • Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism.

    abstract::The stress-activated protein kinases (SAPKs), also known as c-Jun amino-terminal kinases (JNKs), are activated in response to diverse stimuli including DNA damage, heat shock, interleukin-1, tumor necrosis factor-alpha and Fas. Although all these inducers cause apoptosis, whether SAPK/JNK activation is required for ap...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201253

    authors: Chauhan D,Pandey P,Ogata A,Teoh G,Treon S,Urashima M,Kharbanda S,Anderson KC

    更新日期:1997-08-14 00:00:00

  • Copine-III interacts with ErbB2 and promotes tumor cell migration.

    abstract::ErbB2 amplification and overexpression in breast cancer correlates with aggressive disease and poor prognosis. To find novel ErbB2-interacting proteins, we used stable isotope labeling of amino acids in cell culture followed by peptide affinity pull-downs and identified specific binders using relative quantification b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.456

    authors: Heinrich C,Keller C,Boulay A,Vecchi M,Bianchi M,Sack R,Lienhard S,Duss S,Hofsteenge J,Hynes NE

    更新日期:2010-03-18 00:00:00

  • HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells.

    abstract::SH3 and SAM domains are protein interaction motifs that are predominantly seen in signaling molecules, adaptors, and scaffold proteins. We have identified a novel family of putative adaptor genes that includes HACS1. HACS1 encodes a 441 amino acid protein that is differentially expressed in hematopoietic cells and has...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204698

    authors: Claudio JO,Zhu YX,Benn SJ,Shukla AH,McGlade CJ,Falcioni N,Stewart AK

    更新日期:2001-08-30 00:00:00

  • Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation.

    abstract::The transcription factor hypoxia inducible factor 1 (HIF1), an HIF1alpha-aryl hydrocarbon receptor nuclear translocator (ARNT) dimeric factor, is essential to the cellular response to hypoxia. We described a t(1;12)(q21;p13) chromosomal translocation in human acute myeloblastic leukemia that involves the translocated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209503

    authors: Nguyen-Khac F,Della Valle V,Lopez RG,Ravet E,Mauchauffé M,Friedman AD,Huang LE,Fichelson S,Ghysdael J,Bernard OA

    更新日期:2006-08-10 00:00:00

  • The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.

    abstract::Members of the src family of tyrosine kinases are composed of amino acid sequences which can be divided into three regions: the unique amino-terminal 80 residues; the next 180 residues of conserved but non-catalytic sequence; and the catalytic carboxy-terminal half of the molecule. To characterize the elements that re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Espino PC,Chou WY,Smith AE,Cheng SH

    更新日期:1992-02-01 00:00:00

  • p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress.

    abstract::The long-term cellular response to DNA damage is controlled by the tumor suppressor p53. It results in cell-cycle arrest followed by DNA repair and, depending on the degree of damage inflicted, premature senescence or apoptotic cell death. Here we show that in normal diploid fibroblasts the ubiquitin ligase anaphase-p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.99

    authors: Wiebusch L,Hagemeier C

    更新日期:2010-06-17 00:00:00

  • IL-6-independent expression of Mcl-1 in human multiple myeloma.

    abstract::Mcl-1 is a critical antiapoptotic survival factor for human multiple myeloma (MM). We examined the importance of IL-6 for Mcl-1 expression in five MM cell lines and in primary MM cells from 14 patients. While culture of MM.1S cells in IL-6 did induce Mcl-1 expression, four other MM cell lines exhibited high levels of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206358

    authors: Zhang B,Potyagaylo V,Fenton RG

    更新日期:2003-03-27 00:00:00

  • Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.

    abstract::The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents an appealing chemotherapeutic target. Silibinin is a nontoxic flavonoid reported to exhibit anticancer properties. However, the mechanisms by which silibinin inhibits tumour growth are not f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.398

    authors: García-Maceira P,Mateo J

    更新日期:2009-01-22 00:00:00

  • The erythropoietin-receptor pathway modulates survival of cancer cells.

    abstract::Anemia in cancer patients is associated with reduced quality of life and local failure after radiation treatment. However, the use of erythropoietin to correct cancer anemia and to improve radiation efficacy was disappointing. Erythropoietin-receptor signaling mainly acts via activation of STAT 5, but also crossactiva...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208140

    authors: Pajonk F,Weil A,Sommer A,Suwinski R,Henke M

    更新日期:2004-11-25 00:00:00

  • A refined molecular taxonomy of breast cancer.

    abstract::The current histoclinical breast cancer classification is simple but imprecise. Several molecular classifications of breast cancers based on expression profiling have been proposed as alternatives. However, their reliability and clinical utility have been repeatedly questioned, notably because most of them were derive...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.301

    authors: Guedj M,Marisa L,de Reynies A,Orsetti B,Schiappa R,Bibeau F,MacGrogan G,Lerebours F,Finetti P,Longy M,Bertheau P,Bertrand F,Bonnet F,Martin AL,Feugeas JP,Bièche I,Lehmann-Che J,Lidereau R,Birnbaum D,Bertucci F,de

    更新日期:2012-03-01 00:00:00

  • Kinase drug discovery approaches in chronic myeloproliferative disorders.

    abstract::Myeloproliferative disorders (MPDs) are clonal malignancies that arise from hematopoietic progenitors and characterized by overproduction of mature, functional blood cells. These disorders can be broadly characterized into Philadelphia chromosome-positive (Ph(+)) or negative (Ph(-)) genetic groupings. Chronic myeloid ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.107

    authors: Kumar C,Purandare AV,Lee FY,Lorenzi MV

    更新日期:2009-06-18 00:00:00

  • The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.

    abstract::The cytoplasmic tyrosine kinase Src has been implicated in signal transduction induced by growth factors and integrins. Src also shows oncogenic activity when deregulated. Accumulating evidence indicates that the tyrosine kinase Abl is an important substrate for Src signalling in normal cells. Here we show that Abl is...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210543

    authors: Sirvent A,Boureux A,Simon V,Leroy C,Roche S

    更新日期:2007-11-15 00:00:00

  • Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta.

    abstract::Acute myeloid leukemia 1 (AML1) gene on chromosome 21 is involved in several chromosomal translocations, including t(8;21) and t(16;21), that produce chimeric fusion proteins AML1-eight twenty-one (ETO) and AML-myeloid transforming gene chromosome 16 (MTG16), which contribute to leukemogenesis. The molecular basis for...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209431

    authors: Qiu J,Wong J,Tweardy DJ,Dong S

    更新日期:2006-06-29 00:00:00

  • Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.

    abstract::Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer susceptibility is controv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.280

    authors: Mao JH,Wu D,DelRosario R,Castellanos A,Balmain A,Perez-Losada J

    更新日期:2008-11-20 00:00:00

  • Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

    abstract::An essential mode of acquired resistance to radiotherapy (RT) appears to be promotion of tumor cell motility and invasiveness in various cancer types, including glioblastoma, a process resembling 'evasive resistance'. Hence, a logical advancement of RT would be to identify suitable complementary treatment strategies, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.137

    authors: Weiler M,Pfenning PN,Thiepold AL,Blaes J,Jestaedt L,Gronych J,Dittmann LM,Berger B,Jugold M,Kosch M,Combs SE,von Deimling A,Weller M,Bendszus M,Platten M,Wick W

    更新日期:2013-02-28 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.

    abstract::Early Growth Response 1 (EGR1) is a stress response transcription factor with multiple tumour suppressor roles in breast tissue, whose expression is often lost in breast cancers. We have previously shown that the breast cancer oncogene TBX2 (T-BOX2) interacts with EGR1 to co-repress EGR1-target genes including the bre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0853-z

    authors: Crawford NT,McIntyre AJ,McCormick A,D'Costa ZC,Buckley NE,Mullan PB

    更新日期:2019-08-01 00:00:00

  • HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

    abstract::Amplified segments of the long arm of chromosome 12 are frequently observed in human sarcomas. In most cases there are separate amplified regions around the MDM2 and CDK4 genes. Here we show recurrent amplification of a third region encompassing HMGIC, a human architectural transcription factor gene. Reduced amplifica...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201135

    authors: Berner JM,Meza-Zepeda LA,Kools PF,Forus A,Schoenmakers EF,Van de Ven WJ,Fodstad O,Myklebost O

    更新日期:1997-06-19 00:00:00

  • Thrombospondin-4 mediates TGF-β-induced angiogenesis.

    abstract::TGF-β is a multifunctional cytokine affecting many cell types and implicated in tissue remodeling processes. Due to its many functions and cell-specific effects, the consequences of TGF-β signaling are process-and stage-dependent, and it is not uncommon that TGF-β exerts distinct and sometimes opposing effects on a di...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.140

    authors: Muppala S,Xiao R,Krukovets I,Verbovetsky D,Yendamuri R,Habib N,Raman P,Plow E,Stenina-Adognravi O

    更新日期:2017-09-07 00:00:00

  • The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

    abstract::The MTG (Myeloid Translocation Gene) proteins are a family of novel transcriptional corepressors. We report that MTG16a, a protein isoform encoded by the MTG16 gene deranged by the t (16; 21) in myeloid malignancies, is targeted to the nucleolus. The amino acid sequence necessary for nucleolar localization was mapped ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205882

    authors: Hoogeveen AT,Rossetti S,Stoyanova V,Schonkeren J,Fenaroli A,Schiaffonati L,van Unen L,Sacchi N

    更新日期:2002-09-26 00:00:00

  • Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha.

    abstract::A previous report demonstrated that AP-2alpha favors the survival of ovarian cancer patients by clinical findings. However, the functional roles of AP-2alpha in human ovarian cancers have not been determined. To clarify the roles, we overexpressed AP-2alpha in SKOV3 human ovarian cancer cells, which originally possess...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207723

    authors: Sumigama S,Ito T,Kajiyama H,Shibata K,Tamakoshi K,Kikkawa F,Williams T,Tainsky MA,Nomura S,Mizutani S

    更新日期:2004-07-15 00:00:00

  • Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.

    abstract::The epithelium-specific transcription factor, ERT/ESX/ESE-1/ELF3, binds to the TGF-beta RII promoter in a sequence specific manner and regulates its expression. In this study, we investigated whether ERT could regulate endogenous TGF-beta RII expression in Hs578t breast cancer cells. Analyses of the Hs578t parental ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203252

    authors: Chang J,Lee C,Hahm KB,Yi Y,Choi SG,Kim SJ

    更新日期:2000-01-06 00:00:00

  • Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

    abstract::The HER-2/neu proto-oncogene is homologous with, but distinct from, the epidermal growth factor receptor. Current evidence indicates that this gene is frequently amplified and/or overexpressed in some human breast and ovarian cancers and that these alterations may be clinically important; however, little is known abou...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Press MF,Cordon-Cardo C,Slamon DJ

    更新日期:1990-07-01 00:00:00

  • EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy.

    abstract::Mutations in epidermal growth factor receptor (EGFR) kinase domain associate with clinical responses to EGFR inhibitors and are frequently observed in non-small cell lung cancer (NSCLC) patients in East Asian populations. Clinically identified EGFR mutations cause constitutive receptor activation. The activating mecha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210684

    authors: Fu YN,Yeh CL,Cheng HH,Yang CH,Tsai SF,Huang SF,Chen YR

    更新日期:2008-02-07 00:00:00